Whales with a lot of money to spend have taken a noticeably bullish stance on Bristol-Myers Squibb.
Looking at options history for Bristol-Myers Squibb BMY we detected 10 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 30% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $160,750 and 6, calls, for a total amount of $225,501.
What's The Price Target?
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $50.0 and $60.0 for Bristol-Myers Squibb, spanning the last three months.
Volume & Open Interest Trends
In today's trading context, the average open interest for options of Bristol-Myers Squibb stands at 1844.57, with a total volume reaching 10,340.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Bristol-Myers Squibb, situated within the strike price corridor from $50.0 to $60.0, throughout the last 30 days.
Bristol-Myers Squibb Option Activity Analysis: Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY | CALL | SWEEP | BEARISH | 06/20/25 | $1.82 | $1.74 | $1.74 | $60.00 | $82.6K | 3.2K | 537 |
| BMY | PUT | SWEEP | BEARISH | 03/28/25 | $0.6 | $0.56 | $0.6 | $53.00 | $52.3K | 246 | 969 |
| BMY | PUT | SWEEP | BULLISH | 06/20/25 | $1.94 | $1.85 | $1.85 | $52.50 | $44.0K | 4.1K | 239 |
| BMY | PUT | TRADE | BEARISH | 03/28/25 | $0.61 | $0.55 | $0.6 | $53.00 | $38.2K | 246 | 969 |
| BMY | CALL | SWEEP | BULLISH | 02/14/25 | $0.28 | $0.27 | $0.28 | $57.00 | $31.5K | 1.9K | 3.4K |
About Bristol-Myers Squibb
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Present Market Standing of Bristol-Myers Squibb
- With a trading volume of 4,560,473, the price of BMY is down by -0.38%, reaching $55.73.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 71 days from now.
Expert Opinions on Bristol-Myers Squibb
In the last month, 3 experts released ratings on this stock with an average target price of $60.666666666666664.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * An analyst from Cantor Fitzgerald persists with their Neutral rating on Bristol-Myers Squibb, maintaining a target price of $55. * Consistent in their evaluation, an analyst from Citigroup keeps a Neutral rating on Bristol-Myers Squibb with a target price of $65. * An analyst from Wells Fargo has decided to maintain their Equal-Weight rating on Bristol-Myers Squibb, which currently sits at a price target of $62.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Bristol-Myers Squibb with Benzinga Pro for real-time alerts.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
